Dr. Christina Riordan is currently a Senior Director of Integrated Drug Development at Certara. Christina has almost 19 years of industry experience in toxicology working at a CRO and at small and large companies with both biologics and small molecules serving as the toxicology/safety lead on several multidisciplinary drug development teams. Christina has been involved in toxicology and safety pharmacology studies from early to late development including general toxicology and pharmacokinetic studies, genetic toxicology, reproductive toxicology, drug abuse liability studies, cardiovascular studies, and more and has extensive regulatory writing experience. She has worked in many therapeutic areas and most recently with a focus on immuno-oncology and inflammation. Dr. Riordan holds a doctorate in molecular genetics from the University of Albany.
Christina Riordan Sr. Director, Integrated Drug Development